Increased insulin resistance and β cell activity in patients with Crohn's disease

Inflammatory Bowel Diseases

Volumn 12, Issue 1, 2006, Pages 53-56

  Bregenzer, Nicole ^a   Hartmann, Alexander ^a   Strauch, Ulrike ^a   Schölmerich, Jürgen ^a   Andus, Tilo ^b   Bollheimer, L Cornelius ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Department of Internal Medicine Bad Cannstadt ^*  (Germany)

Author keywords

Crohn's disease; Endocrine pancreas function; Oral glucose tolerance test

Indexed keywords

ADULT; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VOLUNTEER;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CROHN DISEASE; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED;

EID: 29744458362     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000195975.97673.f5     Document Type: Article

References (16)

1. Axon ATR, Ashton MG, Lintott DJ. Chronic pancreatitis and inflammatory bowel disease. Clin Radiol. 1979;30:179-182.
2. Eisner TD, Goldman IS, McKinley MJ. Crohn's disease and pancreatitis. Am J Gastroenterol. 1993;8:583-586.
3. Herrlinger KR, Stange EF. The pancreas and inflammatory bowel disease. Int J Pancreatol. 2000;27:171-179.
4. Ball WP, Bargen JA. Pancreatic lesions associated with chronic ulcerative colitis. Arch Pathol. 1950;50:347-358.
5. Hegnhoj J, Hansen CP, Rannem T, et al. Pancreatic function in inflammatory bowel disease. Gut. 1990;31:1076-1079.
6. Angelini G, Cavallini P, Bovo P, et al. Pancreatic function in inflammatory bowel disease. Int J Pancreatol. 1988;3:185-193.
7. Bendet N, Scapa E, Cohen O, et al. Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in Crohn's patients with terminal ileum disease is unrelated to disease activity or ileal resection. Scand J Gastroenterol. 2004;7:650-656.
8. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and β-cell function. Best Pract Res Clin Endocrinol Metab. 2003;17:305-322.
9. Best WR, Mecktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
10. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentrations in man. Diabetologica. 1985;29:412-419.
11. Phillips DI, Clark PM, Hales CN, et al. Understanding oral glucose tolerance: comparison of glucose and insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med. 1994;11:286-292.
12. Tura A, Ludvik B, Nolan JJ, et al. Insulin and C-peptide secretion and kinetics in humans: direct model based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001;281:E966-E974.
13. Orskov C, Bersani M, Johson AH, et al. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem. 1986;261:11880-11889.
14. Elhai D, Meneilly GS, Scalter A, et al. The insulinotropic effect of GIP: a dose response comparison to glucagon-like peptide-1 (7-37) amine (GLP). Digestion. 1990;46(Suppl 1):28.
15. Fehmann HC, Göke R, Göke B, et al. Proming with GLP-1 (7-36) amide, GIP and CCK-8 enhances glucose induced insulin secretion from the isolated perfused rat pancreas. Digestion. 1990;46(Suppl. 1):32-33.
16. Mojsov S, Weir CG, Habner JF. Insulinotropin: glucagon-like peptide 1 (7-36) co-encoded in the glucagon gene is a potent stimulator for insulin release in the perfused rat pancreas. J Clin Invest. 1987;79:616-619.